Nuclear Magnetic Resonance technique in tumor metabolism

Siegel, 2015, Cancer statistics, CA A Cancer J Clin, 65, 5, 10.3322/caac.21254 Torre, 2012, Global cancer statistics, CA A Cancer J Clin, 65, 87, 10.3322/caac.21262 Oken, 2011, Screening by chest radiograph and lung cancer mortality: the prostate, lung, colorectal, and ovarian (plco) randomized trial, JAMA, 306, 1865, 10.1001/jama.2011.1591 Oken, 2005, Baseline chest radiograph for lung cancer detection in the randomized prostate, lung, colorectal and ovarian cancer screening trial, J Natl Cancer Inst, 97, 1832, 10.1093/jnci/dji430 Karahalli, 2001, Usefulness of various diagnostic techniques during fiberoptic bronchoscopy for endoscopically visible lung cancer: should cytologic examinations be performed routinely?, Respiration, 68, 611, 10.1159/000050581 Berrington de González, 2009, Projected cancer risks from computed tomographic scans performed in the United States in 2007, Archives Intern Med, 169, 2071, 10.1001/archinternmed.2009.440 Berrington de González, 2008, Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk, J Med Screen, 15, 153, 10.1258/jms.2008.008052 Padhani, 2009, Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations, Neoplasia, 11, 102, 10.1593/neo.81328 Chenevert, 1997, Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging, Clin Cancer Res, 3, 1457 Juweid, 2006, Positron-emission tomography and assessment of cancer therapy, N Engl J Med, 354, 496, 10.1056/NEJMra050276 Yi, 2013, Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer, Cancer, 119, 1784, 10.1002/cncr.28000 Erasmus, 2008, CT, positron emission tomography, and MRI in staging lung cancer, Clin Chest Med, 29, 39, 10.1016/j.ccm.2007.11.004 Sugimoto, 2010, Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles, Metabolomics, 6, 78, 10.1007/s11306-009-0178-y Claudino, 2012, Metabolomics in cancer: a bench-to-bedside intersection, Crit Rev Oncol Hematol, 84, 1, 10.1016/j.critrevonc.2012.02.009 Patel, 2015, Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery, J Pharm Biomed Anal, 107, 63, 10.1016/j.jpba.2014.12.020 Yizhak, 2010, Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model, Bioinformatics, 26, i255, 10.1093/bioinformatics/btq183 Nicholson, 1989, High resolution proton magnetic resonance spectroscopy of biological fluids, Prog Nucl Magnetic Reson Spectrosc, 21, 449, 10.1016/0079-6565(89)80008-1 Nambiar, 2010, An “Omics” based survey of human colon cancer, Mutat Res Fundam Mol Mech Mutagen, 693, 3, 10.1016/j.mrfmmm.2010.07.008 Raamsdonk, 2001, A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations, Nat Biotechnol, 19, 45, 10.1038/83496 Bino, 2004, Potential of metabolomics as a functional genomics tool, Trends Plant Sci, 9, 418, 10.1016/j.tplants.2004.07.004 Kell, 2006, Systems biology, metabolic modelling and metabolomics in drug discovery and development, Drug Discov Today, 11, 1085, 10.1016/j.drudis.2006.10.004 Nicholson, 1999, ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data, Xenobiotica, 29, 1181, 10.1080/004982599238047 Dunn, 2011, Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy, Chem Soc Rev, 40, 387, 10.1039/B906712B Bathen, 2010, Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation, Cancer Res, 70, 6692, 10.1158/0008-5472.CAN-10-0437 Yang, 2004, Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases, J Chromatogr B, 813, 59, 10.1016/j.jchromb.2004.09.032 Griffin, 2004, Metabolic profiles of cancer cells, Nat Rev Cancer, 4, 551, 10.1038/nrc1390 Woo, 2009, Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers, Clin Chim Acta, 400, 63, 10.1016/j.cca.2008.10.014 Zürbig, 2008 Kolch, 2005, Capillary electrophoresis–mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery, Mass Spectrom Rev, 24, 959, 10.1002/mas.20051 Zhang, 2012, NMR-based metabolomics study of canine bladder cancer, Biochimica Biophysica Acta (BBA) – Mol Basis Dis, 1822, 1807, 10.1016/j.bbadis.2012.08.001 Gebregiworgis, 2012, Application of NMR metabolomics to search for human disease biomarkers, Comb Chem High Throughput Screen, 15, 595, 10.2174/138620712802650522 Zira, 2010, 1H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool, J Proteome Res, 9, 4038, 10.1021/pr100226m Yang, 2008, Profiling of central metabolism in human cancer cells by two-dimensional NMR, GC-MS analysis, and isotopomer modeling, Metabolomics, 4, 13, 10.1007/s11306-007-0094-y de Graaf, 2003, Quantitative 1H NMR spectroscopy of blood plasma metabolites, Anal Chem, 75, 2100, 10.1021/ac020782+ Wilson, 2009, High resolution magic angle spinning 1H NMR of childhood brain and nervous system tumours, Mol Cancer, 8, 1, 10.1186/1476-4598-8-6 DeFeo, 2011, A decade in prostate cancer: from NMR to metabolomics, Nat Rev Urol, 8, 301, 10.1038/nrurol.2011.53 Denkert, 2012, Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery, Genome Med, 4, 37, 10.1186/gm336 Li, 2005, Quantification of choline compounds in human hepatic tumors by proton MR spectroscopy at 3T, Magnetic Reson Med, 53, 770, 10.1002/mrm.20412 Tosi, 2001, Biochemical characterization of human renal tumors by in vitro nuclear magnetic resonance, J Mol Struct, 565–566, 323, 10.1016/S0022-2860(00)00818-8 Zhang, 2013, Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum, Biochimica Biophysica Acta (BBA) – Mol Basis Dis, 1832, 1207, 10.1016/j.bbadis.2013.03.009 Dumas, 2006, Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study, Anal Chem, 78, 2199, 10.1021/ac0517085 Gil, 2015, NMR metabolomics of renal cancer: an overview, Bioanalysis, 7, 2361, 10.4155/bio.15.167 Liu, 1996, High-resolution diffusion and relaxation edited one-and two-dimensional 1H NMR spectroscopy of biological fluids, Anal Chem, 68, 3370, 10.1021/ac960426p Martin-Pastor, 2014, Experiments for the editing of singlet peaks and simplification of 1H NMR spectra of complex mixtures, J Agric food Chem, 62, 1190, 10.1021/jf4044869 Katz-Brull, 1998, Choline metabolism in breast cancer; 2H-, 13C-and 31P-NMR studies of cells and tumors, Magnetic Reson Mater Phys Biol Med, 6, 44, 10.1007/BF02662511 Daly, 1987, Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy, J Biol Chem, 262, 14875, 10.1016/S0021-9258(18)48107-0 Shanaiah, 2007, Class selection of amino acid metabolites in body fluids using chemical derivatization and their enhanced 13C NMR, Proc Natl Acad Sci, 104, 11540, 10.1073/pnas.0704449104 Emwas, 2013, NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations, Metabolomics, 9, 1048, 10.1007/s11306-013-0524-y Duarte, 2012, Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids, Prog Nucl Magnetic Reson Spectrosc, 62, 51, 10.1016/j.pnmrs.2011.11.002 Ah, 2013, NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis, Magnetic Reson Chem, 51, 549, 10.1002/mrc.3985 Tiziani, 2009, Early stage diagnosis of oral cancer using 1H NMR–based metabolomics, Neoplasia, 11, 10.1593/neo.81396 Jordan, 2007, NMR-based metabolomics approach to target biomarkers for human prostate cancer, Expert Rev Proteomics, 4, 389, 10.1586/14789450.4.3.389 DeBerardinis, 2008, The biology of cancer: metabolic reprogramming fuels cell growth and proliferation, Cell Metab, 7, 11, 10.1016/j.cmet.2007.10.002 Rocha, 2011, Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma, J Proteome Res, 10, 4314, 10.1021/pr200550p OuYang, 2011, Metabolomic Profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis, Appl Biochem Biotechnol, 165, 148, 10.1007/s12010-011-9240-0 Slupsky, 2010, Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers, Clin Cancer Res, 16, 5835, 10.1158/1078-0432.CCR-10-1434 Dunne, 2005, Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition 1H NMR study, NMR Biomed, 18, 24, 10.1002/nbm.918 Wei, 2011, Salivary metabolite signatures of oral cancer and leukoplakia, Int J Cancer, 129, 2207, 10.1002/ijc.25881 Monleon, 2009, Metabolite profiling of fecal water extracts from human colorectal cancer, NMR Biomed, 22, 342, 10.1002/nbm.1345 Tomlins, 1998, High resolution magic angle spinning 1H nuclear magnetic resonance analysis of intact prostatic hyperplastic and tumour tissues, Anal Commun, 35, 113, 10.1039/a708098k Beckonert, 2010, High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues, Nat Protoc, 5, 1019, 10.1038/nprot.2010.45 Somashekar, 2011, Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues, J proteome Res, 10, 5232, 10.1021/pr200800w Sykes, 2007, Urine stability for metabolomic studies: effects of preparation and storage, Metabolomics, 3, 19, 10.1007/s11306-006-0042-2 Bernini, 2011, Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks, J Biomol NMR, 49, 231, 10.1007/s10858-011-9489-1 Brown, 2008, Evaluation of sample preparation methods for nuclear magnetic resonance metabolic profiling studies with Eisenia fetida, Environ Toxicol Chem, 27, 828, 10.1897/07-412.1 Reily, 2006, DFTMP, an NMR reagent for assessing the near-neutral pH of biological samples, J Am Chem Soc, 128, 12360, 10.1021/ja063773h Grimes, 2011, The application of micro-coil NMR probe technology to metabolomics of urine and serum, J Biomol NMR, 49, 297, 10.1007/s10858-011-9488-2 Canelas, 2008, Leakage-free rapid quenching technique for yeast metabolomics, Metabolomics, 4, 226, 10.1007/s11306-008-0116-4 Briscoe, 2009, Factors affecting the stability of drugs and drug metabolites in biological matrices, Bioanalysis, 10.4155/bio.09.20 Tiziani, 2008, Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy, Anal Biochem, 377, 16, 10.1016/j.ab.2008.01.037 Psychogios, 2011, The human serum metabolome, PLoS One, 6, e16957, 10.1371/journal.pone.0016957 Rasmussen, 2011, Standardization of factors that influence human urine metabolomics, Metabolomics, 7, 71, 10.1007/s11306-010-0234-7 Beger, 2013, A review of applications of metabolomics in cancer, Metabolites, 3, 552, 10.3390/metabo3030552 Emwas, 2015, Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review, Metabolomics, 11, 872, 10.1007/s11306-014-0746-7 Wang, 2011, 1H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis, Tumor Biol, 32, 223, 10.1007/s13277-010-0116-7 Jonsson, 2005, High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses, Anal Chem, 77, 5635, 10.1021/ac050601e Madsen, 2010, Chemometrics in metabolomics—a review in human disease diagnosis, Anal Chim Acta, 659, 23, 10.1016/j.aca.2009.11.042 Kohl, 2012, State-of-the art data normalization methods improve NMR-based metabolomic analysis, Metabolomics, 8, 146, 10.1007/s11306-011-0350-z Liu, 2013, Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma, World J Gastroenterology WJG, 19, 3423, 10.3748/wjg.v19.i22.3423 Snow, 1994, Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study, J Urol, 152, 1923 Lehnhardt, 2005, Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation, NMR Biomed, 18, 371, 10.1002/nbm.968 Gribbestad, 1994, 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue, NMR Biomed, 7, 181, 10.1002/nbm.1940070405 Bylesjö, 2006, OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification, J Chemom, 20, 341, 10.1002/cem.1006 Goodpaster, 2010, Statistical significance analysis of nuclear magnetic resonance-based metabonomics data, Anal Biochem, 401, 134, 10.1016/j.ab.2010.02.005 Westerhuis, 2010, Multivariate paired data analysis: multilevel PLSDA versus OPLSDA, Metabolomics, 6, 119, 10.1007/s11306-009-0185-z Molteni, 2009, Successful application of OPLS-DA for the discrimination of wild-type and mutated cells in acute lymphoblastic leukemia, QSAR Comb Sci, 28, 822, 10.1002/qsar.200860195 Boccard, 2013, A consensus orthogonal partial least squares discriminant analysis (OPLS-DA) strategy for multiblock Omics data fusion, Anal Chim Acta, 769, 30, 10.1016/j.aca.2013.01.022 Ramadan, 2006, Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms, Talanta, 68, 1683, 10.1016/j.talanta.2005.08.042 Worley, 2013, Utilities for quantifying separation in PCA/PLS-DA scores plots, Anal Biochem, 433, 102, 10.1016/j.ab.2012.10.011 Wishart, 2007, HMDB: the human metabolome database, Nucleic acids Res, 35, D521, 10.1093/nar/gkl923 Ulrich, 2008, BioMagResBank, Nucleic Acids Res, 36, D402, 10.1093/nar/gkm957 Forsythe, 2009, Exploring human metabolites using the human metabolome database, Curr Protoc Bioinforma, 14.18.11 Ludwig, 2009, Fast targeted multidimensional NMR metabolomics of colorectal cancer, Magnetic Reson Chem MRC, 47, S68, 10.1002/mrc.2519 Amiot, 2015, 1H NMR spectroscopy of fecal extracts enables detection of advanced colorectal neoplasia, J Proteome Res, 14, 3871, 10.1021/acs.jproteome.5b00277 Piotto, 2009, Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy, Metabolomics, 5, 10.1007/s11306-008-0151-1 Gao, 2009, Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis, Cancer Sci, 100, 782, 10.1111/j.1349-7006.2009.01086.x Shariff, 2011, Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study, J Proteome Res, 10, 1828, 10.1021/pr101096f Carrola, 2010, Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine, J Proteome Res, 10, 221, 10.1021/pr100899x Sitter, 2006, Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters, NMR Biomed, 19, 30, 10.1002/nbm.992 Jobard, 2014, A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer, Cancer Lett, 343, 33, 10.1016/j.canlet.2013.09.011 Zhang, 2012, Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by 1H nuclear magnetic resonance-based metabonomic profiles, Clin Biochem, 45, 1064, 10.1016/j.clinbiochem.2012.05.012 Jiménez, 2013, 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic “field-effects” enables colorectal cancer staging and prognostication, J Proteome Res, 12, 959, 10.1021/pr3010106 Bertini, 2012, Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer, Cancer Res, 72, 356, 10.1158/0008-5472.CAN-11-1543 Wang, 2013, 1H NMR-based metabolic profiling of human rectal cancer tissue, Mol Cancer, 12, 1 Piotto, 2008, Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy, Metabolomics, 5, 292, 10.1007/s11306-008-0151-1 MuLan, 2011, An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsy, PLoS One, 6, 1 Sitter, 2010, Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy, NMR Biomed, 23, 424, 10.1002/nbm.1478 Giskeødegård, 2010, Multivariate modeling and prediction of breast cancer prognostic factors using mr metabolomics, J Proteome Res, 9, 972, 10.1021/pr9008783 Asiago, 2010, Early detection of recurrent breast cancer using metabolite profiling, Cancer Res, 70, 8309, 10.1158/0008-5472.CAN-10-1319 Carrola, 2011, Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine, J Proteome Res, 10, 221, 10.1021/pr100899x Liu, 2015, Partial least-squares discriminant analysis optimized by particle swarm optimization: application to 1H nuclear magnetic resonance analysis of lung cancer metabonomics, J Chemom, 29, 537, 10.1002/cem.2737 Chen, 2011, Study on metabonomic characteristics of human lung cancer using high resolution magic-angle spinning 1H NMR spectroscopy and multivariate data analysis, Magnetic Reson Med, 66, 1531, 10.1002/mrm.22957 Duarte, 2010, Can nuclear magnetic resonance (NMR) spectroscopy reveal different metabolic signatures for lung tumours?, Virchows Arch, 457, 715, 10.1007/s00428-010-0993-6 Jordan, 2010, Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue–serum pairs, Lung Cancer, 68, 44, 10.1016/j.lungcan.2009.05.012 Rocha, 2010, Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy, J Proteome Res, 9, 319, 10.1021/pr9006574 Yang, 2007, Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR Spectroscopy in conjunction with multivariate data analysis, J Proteome Res, 6, 2605, 10.1021/pr070063h Nahon, 2012, Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis, Clin Cancer Res, 18, 6714, 10.1158/1078-0432.CCR-12-1099 Solinas, 2013, High resolution-magic angle spinning (HR-MAS) NMR-based metabolomic fingerprinting of early and recurrent hepatocellular carcinoma, Metabolomics, 10, 616, 10.1007/s11306-013-0601-2 Bathe, 2011, Feasibility of Identifying pancreatic cancer based on serum metabolomics, Cancer Epidemiol Biomark Prev, 20, 140, 10.1158/1055-9965.EPI-10-0712